China News Service, Beijing, November 21st. Title: Production capacity will be expanded to 1 billion doses per year, and the United States should put aside "vaccine nationalism"
The new crown vaccine is currently the most effective weapon to fight the epidemic. To win this war against the new crown virus on a global scale, if well-equipped developed countries only consider their own "ammunition depots", it will inevitably hinder the international community's fight against the epidemic. The overall situation, even if the country has reached a "full-armed" vaccine, it may be injured by the "war".
According to a recent report in the New York Times, two advisers to US President Biden stated in an interview that the White House will invest billions of dollars to expand U.S. production capacity. The goal is to produce at least 1 billion doses of COVID-19 vaccine each year from the second half of 2022. To increase the supply of vaccines to developing countries.
All parties are highly concerned about the United States' commitment to increase production capacity and external supply, not only because of the serious "vaccine gap" that still exists in the world, but also because of the vaccine nationalism revealed in the United States and the previous "spoofing".
The two data released by the WHO are worthy of attention. One is that on November 12, according to the vaccination target set by the WHO, 40% of the population of all countries should be vaccinated before the end of this year, and an additional 550 million will be needed. Dose vaccine.
Second, on October 28, only about 77 million people in Africa, that is, 6% of the population completed the new crown vaccination, and more than 70% of the rich countries have reached the goal of completing the new crown vaccination for more than 40% of the population.
WHO Director-General Tan Desai said that while some of the countries with the highest rates of new crown vaccination continue to stock more vaccines, low-income countries are still waiting for the vaccine to arrive.
According to data from the US Centers for Disease Control and Prevention website, as of November 19, more than 229.2 million people, or about 69.1% of Americans, had received at least one dose of the new crown vaccine; more than 195.9 million Americans had completed the new crown vaccination, accounting for approximately the total population Of 59%.
Behind this high vaccination rate is the prevalent "vaccine nationalism" in the United States.
After the outbreak, the U.S. pursued unilateralism, withholding anti-epidemic supplies from other countries, banning the export of domestic medical supplies, and madly placing orders for vaccines regardless of actual needs, exposing the nature of its anti-epidemic also "America first".
In particular, the United States has been rushing to buy vaccines since they are still in clinical trials, leaving "hope" only to themselves, and pushing some underdeveloped countries and regions into a desperate situation of "no seed to grow", "oversupply and over-preparation" Even if the United States is facing the expiration of the vaccine, it is unwilling to donate it to countries in need.
Data from the US Centers for Disease Control and Prevention shows that from March to September this year, the United States wasted at least 15.1 million doses of the new crown vaccine.
After arousing international public outrage, the United States had previously made a promise to provide 80 million doses of vaccines, and it was scheduled to be fulfilled by the end of June, but the American aid that squeezed toothpaste was abruptly delayed until August.
Monica Gandhi, a professor of medicine at the University of California, San Francisco, once said: "You know that there is an oversupply of the new crown vaccine here (the United States), and there is a surplus of the new crown vaccine here (the United States)."
According to the analysis of the Brookings Institution, as of September 25, the United States may have 500 million doses of vaccine remaining.
On the one hand, supporting the global fight against the epidemic, on the other hand, closing the door and fighting alone, standing at the crossroads of public health and social morality. How will the United States choose?
It is hoped that the United States, which has promised to expand vaccine production capacity and increase external supply this time, can put aside its "vaccine nationalism". In this global epidemic crisis, it will show the responsibility and responsibility of major powers, so that the "vaccine unity" that the international community has called for is no longer An empty talk.